TY - JOUR
T1 - PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
AU - Auvergne, R.
AU - Wu, C.
AU - Connell, A.
AU - Au, S.
AU - Cornwell, A.
AU - Osipovitch, M.
AU - Benraiss, A.
AU - Dangelmajer, S.
AU - Guerrero-Cazares, H.
AU - Quinones-Hinojosa, A.
AU - Goldman, S. A.
N1 - Funding Information:
This work was supported by the Dr Miriam and Sheldon G Adelson Medical Research Foundation, and by the New York State Stem Cell Research Program. Tissue collection, processing and studies on human tissue derived from Johns Hopkins University were supported by NIH R01NS070024.
Publisher Copyright:
© 2016 Macmillan Publishers Limited.
PY - 2016/7/21
Y1 - 2016/7/21
N2 - Glioblastoma (GBM) remains the most common and lethal intracranial tumor. In a comparison of gene expression by A2B5-defined tumor-initiating progenitor cells (TPCs) to glial progenitor cells derived from normal adult human brain, we found that the F2R gene encoding PAR1 was differentially overexpressed by A2B5-sorted TPCs isolated from gliomas at all stages of malignant development. In this study, we asked if PAR1 is causally associated with glioma progression. Lentiviral knockdown of PAR1 inhibited the expansion and self-renewal of human GBM-derived A2B5+ TPCs in vitro, while pharmacological inhibition of PAR 1 similarly slowed both the growth and migration of A2B5+ TPCs in culture. In addition, PAR1 silencing potently suppressed tumor expansion in vivo, and significantly prolonged the survival of mice following intracranial transplantation of human TPCs. These data strongly suggest the importance of PAR1 to the self-renewal and tumorigenicity of A2B5-defined glioma TPCs; as such, the abrogation of PAR1-dependent signaling pathways may prove a promising strategy for gliomas.
AB - Glioblastoma (GBM) remains the most common and lethal intracranial tumor. In a comparison of gene expression by A2B5-defined tumor-initiating progenitor cells (TPCs) to glial progenitor cells derived from normal adult human brain, we found that the F2R gene encoding PAR1 was differentially overexpressed by A2B5-sorted TPCs isolated from gliomas at all stages of malignant development. In this study, we asked if PAR1 is causally associated with glioma progression. Lentiviral knockdown of PAR1 inhibited the expansion and self-renewal of human GBM-derived A2B5+ TPCs in vitro, while pharmacological inhibition of PAR 1 similarly slowed both the growth and migration of A2B5+ TPCs in culture. In addition, PAR1 silencing potently suppressed tumor expansion in vivo, and significantly prolonged the survival of mice following intracranial transplantation of human TPCs. These data strongly suggest the importance of PAR1 to the self-renewal and tumorigenicity of A2B5-defined glioma TPCs; as such, the abrogation of PAR1-dependent signaling pathways may prove a promising strategy for gliomas.
UR - http://www.scopus.com/inward/record.url?scp=84949057811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949057811&partnerID=8YFLogxK
U2 - 10.1038/onc.2015.452
DO - 10.1038/onc.2015.452
M3 - Article
C2 - 26616854
AN - SCOPUS:84949057811
SN - 0950-9232
VL - 35
SP - 3817
EP - 3828
JO - Oncogene
JF - Oncogene
IS - 29
ER -